{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-389308","form_type":"8-K","ticker":"ARTV","cik":"0001817241","company_name":"Artiva Biotherapeutics, Inc.","filed_at":"2026-09-11T20:21:51+00:00","discovered_at":"2026-09-11T20:23:00.218417+00:00","generated_at":"2026-09-11T20:23:07.623886+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Artiva shareholders approve 5.1M share increase to 2024 equity plan at annual meeting","bullets":["Stockholders approved amendment to 2024 Equity Incentive Plan adding 5,097,095 shares to Share Reserve.","Vote on plan amendment: 32,527,133 for, 6,816,989 against, 22,759 abstentions, 4,640,922 broker non-votes.","Class II directors Brian Daniels, M.D. and Laura Stoppel, Ph.D. elected for three-year terms through 2029.","KPMG LLP ratified as independent auditor for FY2026: 44,000,762 for, 4,325 against, 2,716 abstentions.","Amended plan also counts pre-funded warrant shares in annual automatic reserve increase (starting Jan 1, 2027)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-389308","json":"https://secwatch.observer/filing/0001193125-26-389308.json","markdown":"https://secwatch.observer/filing/0001193125-26-389308.md","text":"https://secwatch.observer/filing/0001193125-26-389308.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1817241/000119312526389308/0001193125-26-389308-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1817241/000119312526389308/artv-20260908.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-11T20:23:07.623886+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}